- Home
- VMRK vs CAH Comparison
VMRK vs CAH Comparison
Compare VMRK & CAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VMRK | CAH |
|---|---|---|
| Founded | 1978 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Other Pharmaceuticals |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.8B | 55.0B |
| IPO Year | 1994 | 1994 |
Fundamental Metrics
Financial Performance| Metric | VMRK | CAH |
|---|---|---|
| Price | $62.12 | $250.63 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 22 | 17 |
| Target Price | $71.62 | ★ $273.47 |
| AVG Volume (30 Days) | ★ 4.1M | 1.5M |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | ★ 4.55% | 0.82% |
| EPS Growth | 8.09 | ★ 12.09 |
| EPS | 0.54 | ★ 7.23 |
| Revenue | $2,701,075,000.00 | ★ $254,248,000,000.00 |
| Revenue This Year | $42.39 | $4.53 |
| Revenue Next Year | $51.23 | $6.05 |
| P/E Ratio | $114.33 | ★ $34.77 |
| Revenue Growth | 4.76 | ★ 14.23 |
| 52 Week Low | $58.64 | $180.45 |
| 52 Week High | $66.45 | $259.21 |
Technical Indicators
Market Signals| Indicator | VMRK | CAH |
|---|---|---|
| Relative Strength Index (RSI) | 51.48 | 58.20 |
| Support Level | $58.64 | $216.88 |
| Resistance Level | $62.26 | $258.76 |
| Average True Range (ATR) | 1.08 | 5.22 |
| MACD | 0.17 | -0.42 |
| Stochastic Oscillator | 47.55 | 59.66 |
Price Performance
Historical ComparisonAbout VMRK Vivmark Residential Common Shares of Beneficial Interest
Vivmark owns a high-quality apartment portfolio with around 184,000 units and is developing another $4.4 billion of residential properties. The company focuses on owning large, high-quality properties in major metropolitan areas of New England, New York/New Jersey, Washington, D.C., California, and the Pacific Northwest.
About CAH Cardinal Health Inc.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.